Episode Details
Back to Episodes
How I built the company with Semprus BioSciences CEO David Lucchino
Published 13 years, 5 months ago
Description
Semprus BioSciences Corp. hopes to reduce the 60,000 deaths and $11 billion in costs related to "surface failures" of vascular catheters with its Sustain technology for coating medical devices.